Survival after allogeneic bone marrow transplantation (BMT) in patients randomised into a trial of IFN-alpha versus chemotherapy: No significant adverse effect of prolonged IFN-alpha administration.

Survival after allogeneic bone marrow transplantation (BMT) in patients randomised into a trial of IFN-alpha versus chemotherapy: No significant adverse effect of prolonged IFN-alpha administration.

Détails bibliographiques
Auteurs principaux:	Shepherd, P, Richards, S, Allan, N
Format:	Journal article
Publié:	1995